Physician profile
Kevin Joseph Caldwell
NPI 1881986909
$39,792.69
in general payments reported to CMS, 2019-2025
37 companies · $13K in 2025
The $13K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,544 · 2020: $4,404 · 2021: $2,246 · 2022: $1,377 · 2023: $4,766 · 2024: $11K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $22K · Food and Beverage: $4,802 · Travel and Lodging: $2,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $21,944.44 |
| Food and Beverage | $4,802.29 |
| Travel and Lodging | $2,475.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $25,268.93 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $3,881.02 | 2021-2025 | Valiant Captivia, Endurant Iis, Na |
| Medtronic Vascular, INC. | $2,754.91 | 2019-2020 | |
| Silk Road Medical, INC. | $1,811.12 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $1,578.91 | 2022-2025 | General - Angiography, Enroute Transcarotid Neuroprotection System, Eluvia |
| W. L. Gore & Associates, INC. | $1,021.72 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Cardiovascular Systems INC. | $790.18 | 2019-2022 | |
| Cook Medical LLC | $534.42 | 2019-2025 | Cook Celect, Tornado |
| Janssen Pharmaceuticals, INC | $372.96 | 2019-2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $236.47 | 2019-2024 | Venovo, Covera |
| Bolton Medical INC | $235.62 | 2021-2025 | Treo Abdominal Stent-Graft System |
| Shape Memory Medical INC. | $149.80 | 2025 | Impede Embolization Plug |
| Penumbra, INC. | $130.00 | 2021 | |
| Endologix LLC | $114.44 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Edwards Lifesciences Corporation | $81.75 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $79.52 | 2019-2024 | Collagenase Santyl, Pico 14 |
| Inari Medical, INC. | $72.75 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $70.65 | 2022 | |
| Artivion, INC. | $60.98 | 2022 | |
| Osiris Therapeutics INC. | $58.79 | 2019 | |
| Terumo Medical Corporation | $53.34 | 2023 | Angio-Seal, Glidewire, Navicross |
| Stryker Corporation | $52.38 | 2025 | Clottriever Bold Catheter |
| Amgen INC. | $38.12 | 2022 | |
| Abbott Laboratories | $36.70 | 2019-2023 | Diamondback Peripheral |
| Baxter Healthcare | $35.85 | 2021-2022 | |
| Ethicon US, LLC | $35.12 | 2023 | Ethicon |
| Kci USA, INC. | $30.20 | 2021-2022 | |
| Lemaitre Vascular, INC. | $28.01 | 2023 | Flexcel Carotid Shunt, Artegraft Vascular Graft |
| Elutia, INC. | $26.10 | 2021 | |
| Becton, Dickinson and Company | $25.63 | 2022 | |
| Tactile Systems Technology INC | $23.89 | 2021 | |
| Heartflow, INC. | $23.63 | 2024 | |
| Medela LLC | $21.64 | 2021 | |
| Kerecis Limited | $19.14 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Covidien Lp | $18.24 | 2019 | |
| Sanara Medtech INC. | $14.87 | 2023 | Celleraterx |
| Nuwellis, INC. | $4.89 | 2023 | Aquadex Smartflow Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.